The United States Patent & Trademark Office has issued patent 12/363,479 entitled "Extracellular matrix compositions for the treatment of cancer" to Histogen, covering compositions of proteins secreted by multipotent stem cells for use in the treatment of cancer. Histogen Oncology, a company developing innovative cancer therapies based on Histogen's regenerative medicine technology, today announced that the United States Patent & Trademark Office has issued patent 12/363,479 entitled "Extracellular matrix compositions for the treatment of cancer" to Histogen.
http://ift.tt/1v1ivFH
http://ift.tt/1v1ivFH
No comments:
Post a Comment